Antisense oligonucleotides and thier use for the treatment of cancer
US-2023016983-A1 · Jan 19, 2023 · US
This page is not indexed by search engines while we improve data quality.
Lnserm Institut National De La Sante Et De La Rech Medicale patents
Lnserm Institut National De La Sante Et De La Rech Medicale holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Jul 15, 2021 |
| Latest publication | Jan 19, 2023 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Method of controlling fluid flow exiting infusion pumps
US-2021268183-A1 · Sep 2, 2021 · US
Compounds with biguanidyl radical and uses thereof
US-2021230105-A1 · Jul 29, 2021 · US
Vascular stent with antithrombotic properties
US-2021213178-A1 · Jul 15, 2021 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Antisense oligonucleotides and thier use for the treatment of cancer
US-2023016983-A1 · Jan 19, 2023 · US
Method of controlling fluid flow exiting infusion pumps
US-2021268183-A1 · Sep 2, 2021 · US
Compounds with biguanidyl radical and uses thereof
US-2021230105-A1 · Jul 29, 2021 · US
Vascular stent with antithrombotic properties
US-2021213178-A1 · Jul 15, 2021 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 2 |
| Physics | 1 |